Send us Fan Mail
Episode Summary: Can a clinical trial site network legally enforce a standardized, templated employment agreement containing restrictive covenants against a Principal Investigator (PI) across state lines? In this episode of the KF Deep Dive, host Darshan Kulkarni breaks down why relying on "corporate uniformity" and copy-pasted employment templates is a ticking legal time bomb for scaling site networks.
Darshan explains how widely divergent state statutes governing healthcare non-competes—ranging from complete bans in states like Washington to strict statutory carve-outs in Texas—render standardized agreements completely unenforceable or even unlawful. He unpacks the downstream risks to Clinical Trial Agreements (CTAs), choice-of-law clauses, and sponsor relationships when a high-performing PI leaves and takes key protocols or study coordinators with them.
What You'll Learn in This Episode:
- The Template Trap: Why one master employment agreement with standard non-compete/non-solicit provisions fails across multiple state jurisdictions.
State Law Fracture: How state-specific rules (e.g., Washington bans, Virginia severance conditions, Texas statutory buyouts) invalidate one-size-fits-all contracts.
Judicial Modification Differences: Blue-pencil states vs. non-severability states, and why overly broad clauses can expose employers to statutory penalties.
- Impact on Clinical Trial Agreements: How PI turnover and contract disputes directly imperil study oversight, sponsor continuity, and trial pipelines.
- 4 Actionable Steps for Site Owners: How to conduct multi-state audits, transition from broad non-competes to hyper-tailored non-solicits, and leverage retention structures over trade restraints.
Support the show
www.kulkarnilawfirm.com